Chad JD - Ensign Executive Officer
| ENSG Stock | USD 145.20 1.16 0.79% |
Executive
Chad JD is Executive Officer of The Ensign Group
| Age | 46 |
| Address | 29222 Rancho Viejo Road, San Juan Capistrano, CA, United States, 92675 |
| Phone | 949 487 9500 |
| Web | https://ensigngroup.net |
Ensign Management Efficiency
The company has return on total asset (ROA) of 0.0402 % which means that it generated a profit of $0.0402 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1496 %, meaning that it created $0.1496 on every $100 dollars invested by stockholders. Ensign's management efficiency ratios could be used to measure how well Ensign manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Ensign's Return On Tangible Assets are most likely to slightly decrease in the upcoming years. The Ensign's current Return On Assets is estimated to increase to 0.08, while Return On Capital Employed is projected to decrease to 0.07. At this time, Ensign's Total Current Assets are most likely to increase significantly in the upcoming years. The Ensign's current Non Current Assets Total is estimated to increase to about 3.3 B, while Intangible Assets are projected to decrease to roughly 6.2 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Brett Bearfield | Acadia Healthcare | N/A | |
| Lynette CPA | Pennant Group | 46 | |
| Nicole Maggio | Option Care Health | 42 | |
| Michael Nelson | Universal Health Services | N/A | |
| Edward Sim | Universal Health Services | 52 | |
| Julie Koenig | Option Care Health | N/A | |
| Victor Radina | Universal Health Services | N/A | |
| Gretchen Hommrich | Acadia Healthcare | N/A | |
| Heather CPA | Acadia Healthcare | 52 | |
| Isa Diaz | Acadia Healthcare | N/A | |
| Bridget Sherick | Select Medical Holdings | N/A | |
| Benson Yang | Option Care Health | N/A | |
| MS DO | Encompass Health Corp | 64 | |
| Geraldine Geckle | Universal Health Services | N/A | |
| Mark Brewer | Enhabit | N/A | |
| Nasser MD | Acadia Healthcare | 45 | |
| Caroline Budde | Option Care Health | N/A | |
| Kristi Jensen | Surgery Partners | N/A | |
| Caitlin Franklin | Amedisys | N/A | |
| Andrew Lynch | Acadia Healthcare | N/A | |
| John Duggan | Select Medical Holdings | N/A | |
Management Performance
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0402 |
Ensign Group Leadership Team
Elected by the shareholders, the Ensign's board of directors comprises two types of representatives: Ensign inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ensign. The board's role is to monitor Ensign's management team and ensure that shareholders' interests are well served. Ensign's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ensign's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Chad Keetch, Executive VP and Secretary | ||
| Suzanne Snapper, Executive CFO | ||
| Beverly Wittekind, General Counsel and VP | ||
| Suzanne CPA, Executive CFO | ||
| Kevin Reese, President Inc | ||
| Spencer Burton, President COO | ||
| Barry Port, COO of Ensign Services, Inc | ||
| Chad JD, Executive Officer | ||
| Christopher Christensen, Co-Founder, CEO and President Director and Member of Quality Assurance and Compliance Committee |
Ensign Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ensign a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0402 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 9.83 B | ||||
| Shares Outstanding | 57.3 M | ||||
| Shares Owned By Insiders | 3.29 % | ||||
| Shares Owned By Institutions | 96.80 % | ||||
| Number Of Shares Shorted | 1.99 M | ||||
| Price To Earning | 29.50 X |
Currently Active Assets on Macroaxis
When determining whether Ensign Group is a strong investment it is important to analyze Ensign's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ensign's future performance. For an informed investment choice regarding Ensign Stock, refer to the following important reports:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in The Ensign Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ensign. If investors know Ensign will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ensign listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.207 | Dividend Share 0.24 | Earnings Share 4.13 | Revenue Per Share 72.801 | Quarterly Revenue Growth 0.15 |
The market value of Ensign Group is measured differently than its book value, which is the value of Ensign that is recorded on the company's balance sheet. Investors also form their own opinion of Ensign's value that differs from its market value or its book value, called intrinsic value, which is Ensign's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ensign's market value can be influenced by many factors that don't directly affect Ensign's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ensign's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ensign is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ensign's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.